Form 4: Cardlytics Director Andre J. Fernandez Reports Stock Transaction

Director Andre J. Fernandez reports the vesting and acquisition of 4,310 shares of Cardlytics, Inc. common stock on January 1, 2025, through the vesting of restricted stock units.

Summary

• On January 1, 2025, Andre J. Fernandez, a director of Cardlytics, Inc., reported a transaction involving the vesting of restricted stock units (RSUs).
• The transaction resulted in the acquisition of 4,310 shares of Cardlytics common stock.
• The RSUs, granted on January 1, 2024, vested in full on the one-year anniversary of the grant date.
• Following the transaction, Fernandez directly owns 4,310 shares of Cardlytics common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Positives

• The vesting of RSUs indicates that performance or time-based conditions have been met, which can be seen as a positive signal.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This particular filing indicates the vesting of previously granted equity compensation.

Key Dates